5PSQ-043 Nebulised voriconazole in lung transplant recipients: analysis of use, efficacy and tolerability

BACKGROUND: Fungal infection is a significant source of morbidity and mortality in lung-transplant recipients (LTR). To avoid systemic toxicity, various nebulised antifungal agents are used after transplant to prevent or treat invasive fungal infections (IFI). Nebulised liposomal amphotericin B (n-L...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Eur J Hosp Pharm
Päätekijät: Mira, ML Ibarra, Perez, M Aguilar, Carreño, B Basagoiti, Guerrero, A Sanchez
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: BMJ Group 2018
Aiheet:
Section 5: Patient safety and quality assurance
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC7535448/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/ejhpharm-2018-eahpconf.397
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia